Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2014 Q2- Text added to 2014 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
add, Agriculture, alleged, anti, antibody, arm, ASCO, Astrazenca, AstraZeneca, Biologika, BLA, book, checkpoint, Chemistry, choice, CMC, Codification, copy, core, corrective, cure, defective, deleted, depict, dispose, export, exported, facilitate, FASBissued, Fifty, force, gene, German, GmbH, goal, IDT, index, industry, inhibitor, IRB, JLS, kill, Leave, liable, licensure, MedImmune, Merck, Microcap, modify, monoclonal, monocytogenesbacteria, monotherapy, negotiate, neutralize, pembrolizumab, persistent, physician, prescribed, preserve, principle, procure, procurement, produce, promised, Proposed, PSA, purported, purporting, quality, rare, recall, repair, repairing, Russell, SAC, ship, sixty, SPA, Standstill, subcontract, submission, Subtopic, supersede, Thousand, timeframe, USDA, valuable, version, vitro, widely
Valuein 2014 Q2 filing- Value in 2014 Q3 filing
Original filings
Filing view